Clinical Trials Browser

Brain Neoplasms × Aminolevulinic Acid × 90 days × Clear all

NCT06907485 2026-01-21

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

Phase 2 Not yet recruiting

Brain Neoplasms